Immune response of human propagated gammadelta-T-cells to neuroblastoma recommend the Vdelta1+ subset for gammadelta-T-cell-based immunotherapy.

Journal of immunotherapy (Hagerstown, Md. : 1997)

Volumn 31, Issue 9, 2008, Pages 896-905

  Schilbach, Karin ^a   Frommer, Klaus ^a   Meier, Sybille ^a   Handgretinger, Rupert ^a   Eyrich, Matthias ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; LYMPHOCYTE ANTIGEN RECEPTOR; T CELL RECEPTOR VDELTA2, HUMAN; T-CELL RECEPTOR VDELTA2, HUMAN;

ARTICLE; CELL DIFFERENTIATION; CELL LINEAGE; CELL MOTION; CYTOTOXICITY; GENE EXPRESSION PROFILING; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; NEUROBLASTOMA; PATHOLOGY; SECRETION; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL; TUMOR CELL LINE; TUMOR ESCAPE;

CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL LINEAGE; CELL MOVEMENT; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; GENE EXPRESSION PROFILING; HUMANS; IMMUNITY, INNATE; NEUROBLASTOMA; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTE SUBSETS; TH1 CELLS; TH2 CELLS; TUMOR ESCAPE;

EID: 67650178621     PISSN: None     EISSN: 15374513     Source Type: Journal    
DOI: None     Document Type: Article

References (0)